South Korea Daily Briefing

Korea's semiconductor exports through May 20 are tracking for a potential all-time monthly record, following March 2026's $32.8 billion peak. Total country exports for May are forecast at $73-75 billion, with chips the dominant category. Samsung Electronics and SK Hynix's HBM memory products remain in critically short supply as AI training chip demand from U.S. hyperscalers shows no signs of slowing. A May record would confirm that the HBM supercycle is extending into mid-2026, a significant positive for both companies' Q2 earnings guidance.

Korea's tourism industry faces a structural demand surge as the 2026 FIFA World Cup drives North America tourism with Canada showing +60% demand growth and Mexico +24%, per the Korea Tourism Organization data. Korean investors tracking tourism, aviation, and hospitality sectors benefit from the demand spike as Korean carriers and travel platforms serving North American Korean diaspora see elevated bookings. Hana Tour and Modetour are the listed Korean travel names most exposed to this outbound tourism demand surge.

Korea's biotech sector is seeing competitive intensity in the fatty liver (MASH/NASH) treatment space, where multiple Korean pharmaceutical companies are racing to develop first-generation treatments. This sector competition mirrors global NASH drug races where major pharma companies (Eli Lilly, Novo Nordisk, Roche) have already committed multi-billion dollar R&D programs. For KOSDAQ biotech investors, the Korean NASH pipeline represents a potential licensing opportunity to global pharma as the first approved NASH treatments begin to validate the market size.